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Abstract
Lower skeletal muscle mitochondrial oxidative phosphorylation capacity (OXPHOS) and intramyocellular lipid (IMCL)
accumulation have been implicated in the etiology of insulin resistance (IR) in obesity. The purpose of this study was to
examine the impact of endurance exercise on biochemical and morphological measures of IMCL and mitochondrial content,
and their relationship to IR in obese individuals. We examined mitochondrial content (subunit protein abundance and
maximal activity of electron transport chain enzymes), IMCL/mitochondrial morphology in both subsarcolemmal (SS) and
intermyofibrillar (IMF) regions by transmission electron microscopy, and intracellular lipid metabolites (diacylglycerol and
ceramide) in vastus lateralis biopsies, as well as, the homeostasis model assessment index of IR (HOMA-IR) prior to and
following twelve weeks of an endurance exercise regimen in healthy age- and physical activity-matched lean and obese
men. Obese men did not show evidence of mitochondrial OXPHOS dysfunction, disproportionate IMCL content in sub-
cellular regions, or diacylglycerol/ceramide accretion despite marked IR vs. lean controls. Endurance exercise increased
OXPHOS and mitochondrial size and density, but not number of individual mitochondrial fragments, with moderate
improvements in HOMA-IR. Exercise reduced SS IMCL content (size, number and density), increased IMF IMCL content, while
increasing IMCL/mitochondrial juxtaposition in both regions. HOMA-IR was inversely associated with SS (r =20.34;
P= 0.051) and IMF mitochondrial density (r =20.29; P= 0.096), IMF IMCL/mitochondrial juxtaposition (r =20.30; P= 0.086),
and COXII (r =20.32; P= 0.095) and COXIV protein abundance (r =20.35; P= 0.052); while positively associated with SS IMCL
size (r = 0.28; P= 0.119) and SS IMCL density (r = 0.25; P= 0.152). Our findings suggest that once physical activity and
cardiorespiratory fitness have been controlled for, skeletal muscle mitochondrial and IMCL profile in obesity may only
partially contribute to the development of IR.
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Introduction
Obesity is a major risk factor for the development of insulin
resistance and many chronic diseases, such as type 2 diabetes
mellitus (T2D) [1]. Although the causal factor mediating insulin
resistance in obesity remains elusive, defects in skeletal muscle
mitochondrial function [2,3,4,5,6,7,8] including aberrant mito-
chondrial morphology [2,9] and reduced expression of genes
responsible for oxidative metabolism [10,11] leading to accumu-
lation of intramyocellular lipid (IMCL) have been proposed as
mechanisms mediating the disease process. As such, several studies
have shown an inverse association between skeletal muscle IMCL
content and whole-body insulin sensitivity in obese individuals
[12,13] and those with T2D [14,15,16]. Similarly, intracellular
fatty acid intermediates, such as diacylglycerol (DAG) and/or
ceramides, possibly produced due to impaired mitochondrial
metabolism, have been shown to interfere with insulin signaling
[17,18,19,20]. These findings have led to the hypothesis that
reduced mitochondrial content and/or oxidative capacity in
skeletal muscle contributes to insulin resistance - a hallmark of
obesity and T2D [8,21,22].
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Skeletal muscle is composed of two distinct mitochondrial
subpopulations, i.e., subsarcolemmal (SS) and intermyofibrillar
(IMF) mitochondria [23]. Ritov et al. reported that electron
transport chain (ETC) activity of SS mitochondria was lower in
obese individuals with or without T2D vs. lean controls [3]. A
more recent report indicated that IMF mitochondria content was
lower in subjects with T2D but SS mitochondrial content was
similar compared with insulin-sensitive subjects [24]. Much like
mitochondrial subpopulations, skeletal muscle is composed of two
distinct IMCL pools, which also reside in SS and IMF regions.
Despite a direct association between aberrant IMCL accumulation
and increased insulin resistance [13,25,26], there is a paucity of
data specifically examining the potential alteration in SS and IMF
IMCL pools in obesity or T2D [27]. Hence, it remains to be
elucidated if differential alterations in mitochondrial and IMCL
subpopulations are etiologically linked to the development of
insulin resistance/T2D.
It is important to note that in the aforementioned studies [3,24]
physical fitness was not strictly controlled which is intimately
associated with skeletal muscle mitochondrial dysfunction [28]. It
is becoming extremely important to define and match subjects
(lean vs. obese vs. T2D) based on their physical activity and fitness
levels to prevent the confounding effect of sedentary lifestyle on
muscle mitochondrial metabolism and IMCL content. Much like
obese and T2D subjects, endurance-trained athletes also exhibit
higher IMCL content, coupled with an increased abundance of
mitochondria and heightened insulin sensitivity [15,26,29]. This
paradox points to physical activity as a major determinant of the
IMCL/mitochondrial relationship in human skeletal muscle. This
paradox has also challenged the concept that the accumulation of
IMCL within skeletal muscle is invariably linked to insulin
resistance.
Taken together, it is evident that the nature of mitochondrial
functional pathology and the causal axis between mitochondrial
dysfunction, aberrant IMCL accumulation, and development of
insulin resistance/T2D remains elusive. Furthermore, the impact
of endurance exercise on the compartmentalization of IMCL
droplets and mitochondria is poorly understood. The current
study aimed to clarify this association by examining several
biochemical measures of mitochondrial components which are
used as biomarkers of mitochondrial content as well as morpho-
logical measures of mitochondrial content in skeletal muscle of
obese men and their age- and physical activity-matched lean
counterparts. We also examined the influence of moderate-
intensity endurance exercise training on skeletal muscle adapta-
tions in both lean and obese subjects.
Materials and Methods
Subjects
Men were recruited through local advertisements and under-
went a telephone and an in-person interview to assess eligibility.
The Research Ethics Board of McMaster University approved the
experimental protocol (REB project #: 05–053), and subjects
provided written informed consent prior to participation in
accordance with the Declaration of Helsinki. Inclusion criteria
included age from 20–55 years and body mass index (BMI) of
18.5–24.9 kg/m2 for lean and $30.0 kg/m2 for obese individuals
with a self-reported stable body weight during the previous 6
months. Individuals who had evidence of T2D, hypertension
(.140/90 mmHg), and/or an abnormal exercise stress test,
smoked, had orthopedic contraindications to physical activity, or
used lipid-lowering, glucose-lowering, antihypertensive, antide-
pressant or weight-loss medications, or consumed more than two
alcoholic beverages per day were excluded. Participants were only
involved in routine activities of daily living (walking, gardening,
etc.) and not engaged in regular structured or individualized
aerobic or strength training programs or athletics. Twenty-four
men enrolled in the study, and experimental groups were matched
for age and cardiorespiratory fitness (VO2peak/kg FFM/min) when
corrected for fat-free mass FFM (Table 1). Six men (3 in the lean
group, 3 in the obese group) did not complete the study because of
inability/unwillingness to comply with protocol or due to personal
or work-related conflicts.
Protocol
All subjects underwent a 12-week endurance exercise training
protocol on a stationary cycle ergometer (Monarck, Cardio Care
827 E), as previously described [30]. Briefly, the protocol
commenced with two 30-min biking sessions at 50% VO2peak
per week in the first week and increased to three 60-min biking
session at 70% VO2peak per week by the final week of training. To
ensure that subjects were cycling at the appropriate intensity, heart
rate (a proxy for VO2peak) was used to monitor training intensity
based on heart rate measurements obtained during the VO2peak
test.
Metabolic Assessments
Prior to and following the intervention (48-h after the last
training session), all participants underwent evaluation of insulin
resistance, body composition, physical fitness, and had a muscle
biopsy. After an overnight fast, the glycemic response to a 75-g
oral glucose load (300 mL) was determined. Blood samples were
collected before and 30, 60, 90 and 120 min during the oral
glucose tolerance test (OGTT). For estimation of whole-body
insulin resistance from data obtained during the OGTT, the
homeostasis model assessment index of insulin resistance (HOMA-
IR) [31] was calculated according to the following equation:
HOMA-IR= I06G0/22.5; where I0 is the fasting insulin concen-
tration (in mU/mL), G0 is the fasting glucose concentration (in
mM). The HOMA-IR has been validated against the euglycemic-
hyperinsulinemic clamp, with correlations ranging from
r=20.725, P,0.0001 [32] to Rs= 0.88, P,0.0001 [31]. Fat
mass, FFM, and body fat percentage were assessed by dual energy
X-ray absorptiometry (GE Lunar, Prodigy, Madison, WI). A
symptom-limited maximal oxygen consumption test (VO2peak) was
determined on an electronically braked cycle ergometer and a
computerized open-circuit gas collection system (Moxus Modula-
tor VO2 system with O2 analyzer S-3A/I and CO2 analyzer CD-
3A, AEI Technologies Inc., Pittsburgh, PA). Subjects cycled
(Excalibur Sport, Lode, Groningen, Netherlands) at 50 W for
1 min, thereafter increasing in increments of 25 W/min. VO2peak
was established when O2 consumption values reached a plateau or
was the highest value during the incremental ergometer protocol,
pedal revolutions could not be maintained over 60 rpm despite
vigorous encouragement, and the respiratory exchange ratio was
more than 1.12. Subjects were monitored using a 12-lead ECG to
rule out any cardiovascular abnormalities.
Blood Sample Analysis
Blood samples were taken from the antecubital vein after an
overnight fast, collected in heparinized vials, placed on ice,
centrifuged at 1750 g for 10 min, and stored at 280uC until
subsequent analysis. Serum free-fatty acid (FFA) concentration was
determined using a commercially available ELISA kit (NEFA kit,
Wako Diagnostics, Richmond, VA). Plasma glucose concentration
was determined using an automated glucose analyzer (2300 STAT
plus, YSI, UK). Plasma insulin concentration was determined
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using a commercially available ELISA kit (INS kit, BioSource,
Belgium, EU).
Muscle Biopsies
Samples of vastus lateralis were obtained after an overnight
fast, as previously described [29]. Biopsies were taken from the
same leg prior to and following the intervention with 3–5 cm
between the incision sites. Approximately 150 mg muscle tissue
was obtained each time and immediately dissected of any
adipose and connective tissue. A portion was saved for
transmission electron microscopy (TEM) analysis and the
remainders immediately flash frozen in liquid nitrogen. Samples
were stored at 280uC for subsequent biochemical and
molecular analysis.
Transmission Electron Microscopy
TEM was used to determine IMCL and mitochondrial
characteristics, as previously described [29]. Samples were viewed
at 6,5006 using a JEOL 1200EX transmission electron micro-
scope. Sixteen micrographs were acquired from 8 randomly
sampled longitudinal sections of muscle fibers (2 micrographs/
fiber) from each individual muscle - one micrograph acquired near
the cell surface representing the SS region and the other acquired
of parallel bundles of myofibrils representing the IMF region.
Lipid droplets and mitochondrial fragments were circled and
converted to actual size using a calibration grid. For each set of 16
images, mean IMCL or mitochondrial size (mm2), total number of
IMCL droplets or mitochondria per square micrometer of tissue
(#/mm2), percentage IMCL or mitochondrial area density (i.e.,
the fraction of cell area occupied by IMCL or mitochondria), and
the percentage of IMCL in contact with mitochondria were
calculated in the IMF and SS compartments by digital imaging
software (Image Pro Plus, ver. 4.0; Media Cybernetics, Silver
Springs, MD), as previously described [29]. The reference for SS
space quantification was the cytoplasmic space between the
sarcolemma and the first layer of myofibrils.
Homogenization and Immunoblotting
Total protein was extracted from frozen biopsy samples, as
previously described [29]. The Lowry assay was used to quantify
the total protein content [33]. Proteins were resolved on either 7.5,
10 or 12.5% SDS-PAGE gels, transferred onto HybondH ECL
nitrocellulose membranes (Amersham), and immunoblotted using
the following commercially available primary antibodies: anti-
COX subunit II (cytochrome c oxidase - subunit II, MS405) and
anti-COX subunit IV (cytochrome c oxidase - subunit IV, MS408)
were purchased from MitoSciences; anti-GLUT4 from Chemicon
(ab1346); anti-phospho-Akt (Ser473, 4060) and anti-PGC-1a
(peroxisome proliferator-activated receptor-c coactivator-1a,
4187) from Cell Signaling Technology. The anti-CS (citrate
synthase) antibody was a generous gift by Dr. Brian Robinson
(The Hospital for Sick Children, Toronto, ON). Anti-b-actin
(612657, BD Biosciences) was used as a loading control.
Membranes were then incubated with the appropriate anti-mouse
or anti-rabbit horseradish peroxidase-conjugated secondary anti-
body and visualized by enhanced chemiluminescence detection
reagent (Amersham). Relative intensities of the protein bands were
digitally quantified using ImageJ Version 1.37 statistical analysis
software.
Diacylglycerol and Ceramide
Muscle DAG and ceramide content was determined as
previously described [34]. Briefly, lipids were extracted from
freeze-dried muscle, and DAG kinase and [32P]ATP were added
to samples preincubated with cardiolipin/oxtylglucoside and
allowed to react for 2 h. The reaction was stopped and samples
were spotted onto thin-layer chromatography plates and
developed. Bands representing 32P-labelled phosphatidic acid
and ceramide-1-phosphate were dried, scraped from the plate
and counted using a liquid scintillation analyzer (Tri-Carb,
2500TR).
Enzyme Activity
Muscle lysate CS (EC 2.3.3.1), complex IV (COX, EC 1.9.3.1),
and b-oxidation (short-chain b-hydroxyacyl-CoA dehydrogenase,
SCHAD) activity was determined, as previously described [29]. All
samples were analyzed in duplicate on a UV spectrophotometer
(Cary 300 Bio UV-Visible spectrophotometer, Varian, Palo Alto,
CA) and expressed as nmol.min21.mg protein21.
Table 1. Participant characteristics.
Lean Obese
Pre-training Post-training Pre-training Post-training
n 9 9
Age (yr) 3863 3963
Height (cm) 17963 18063
Body weight (kg) 75.563.4 75.263.2 108.466.1A 107.166.5B
BMI (kg.m22) 23.660.5 23.560.5 33.661.6A 33.161.7B
Waist circumference (cm) 86.261.4 82.561.7C 111.863.7A 108.664.2B,C
Fat mass (kg) 14.961.9 14.462.1 35.763.3A 35.263.5B
Fat-free mass (kg) 57.362.6 57.962.5 68.862.7A 68.262.9B
Body fat (%) 20.562.3 19.762.5 33.761.4A 33.561.5B
Aerobic capacity (mL O2.kg
21 fat-free mass.min21) 46.962.1 55.562.4C 44.662.1 51.162.0C
Data are presented as means 6 SEM.
AObese group data significantly different from lean group data, P#0.01.
BObese group data significantly different from lean group data, P#0.02.
CPost-training significantly different from pre-training (main effect), P#0.001.
doi:10.1371/journal.pone.0066322.t001
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Total DNA Isolation
Total DNA was isolated from ,15 mg of skeletal muscle using
the Qiagen total DNA isolation kit (Qiagen, Mississauga, ON)
according to the manufacturer’s instructions. DNA samples were
treated with RNase (Fermentas, Mississauga, ON) to remove RNA
contamination. DNA concentration and quality was assessed using
Nanodrop 2000 (Thermo Scientific, Wilmington, DE).
Mitochondrial DNA Content
Mitochondrial DNA (mtDNA) copy number, relative to the
diploid chromosomal DNA content was quantitatively analyzed in
skeletal muscle using ABI 7300 real-time PCR (Applied Biosys-
tems, CA). Primers were designed around ND1 (forward primer,
L3485–3504; reverse primer, H3532–3553) and ND4 (forward
primer, L12087–12109; reverse primer, H12140–12170) regions
of the mitochondrial genome. Nuclear b-globin gene was used as a
housekeeping gene.
Statistical Analysis
When analyzing differences between lean and obese individuals,
statistical analyses were completed using unpaired Student’s t-tests
for independent samples (Statistica, Version 5.0, Statsoft, Tulsa,
OK) with adiposity (lean, obese) being the experimental condition.
A two-way repeated measures ANOVA (Statistica, Version 5.0,
Statsoft, Tulsa, OK) with adiposity (lean, obese) and training (pre,
post) being the experimental conditions was completed when
analyzing the effect of the endurance exercise training program.
When statistical significance was achieved, a Tukey’s HSD post-
hoc test was used to identify individual differences. Pearson
correlation analyses were performed using GraphPad Prism
(Version 4, GraphPad Software, San Diego, CA). Statistical
significance was established at P#0.05. Data are presented as
means 6 SEM.
Results
Lean and Obese Subject Baseline Characterization
Subject characteristics. Lean and obese men were group
matched for age and aerobic capacity. A comprehensive
anthropometrical description of the participants is provided in
Table 1 and Table 2. Body weight, BMI, waist circumference, fat
mass, FFM, and body fat percentage were markedly higher in
obese men vs. lean men (Table 1). Fasting serum triglyceride and
FFA levels were significantly elevated, whereas fasting serum HDL
cholesterol concentrations were significantly lower in obese men vs.
lean men (Table 2).
Oral glucose tolerance test and insulin resistance. 2-h
plasma glucose levels as well as fasting and 2-h plasma insulin
levels were significantly higher in obese men vs. lean men (Table 2).
Plasma concentrations of glucose (AUCglucose; Figure 1A) and
insulin (AUCinsulin; Figure 1B) during the OGTT were signifi-
cantly higher in obese men vs. lean men. Assessment of insulin
resistance with the HOMA-IR showed 68% greater insulin
resistance in obese men vs. lean men (3.3160.47 vs. 1.9760.26,
P#0.02; Figure 1C).
Biomarkers of mitochondrial content. The transcriptional
co-activator PGC-1a is widely regarded as the master regulator of
mitochondrial biogenesis [35,36]. We found no difference in whole
muscle protein content of PGC-1a between lean and obese men
(Figure 2A). We further analyzed the expression of several key
nuclear- and mtDNA encoded proteins that are involved in
mitochondrial energy metabolism. The protein content of CS
(marker of mitochondrial abundance), COX subunit II (COXII;
mtDNA-encoded) and subunit IV (COXIV; nuclear DNA
encoded), as well as the maximal activities of CS, COX, and
SCHAD (marker of mitochondrial b-oxidation) were similar in
both lean and obese men (Figure 2, A and B). We also measured
mtDNA copy number in skeletal muscle and observed no
between-group differences (Figure 2C).
Intramyocellular lipid and mitochondrial
content. IMCL and mitochondria are heterogeneously distrib-
uted in myofibers. Two sub-cellular fractions of IMCL and
mitochondria were characterized based on their location in both
the SS and IMF regions. Electron micrographs illustrating these
subpopulations are shown in Figure 3A–D. A summary of both
IMCL and mitochondrial morphology and sub-cellular distribu-
tion is provided in Table 3. The IMCL and mitochondrial content
in both the SS and IMF sub-cellular regions were similar in lean
and obese men (Figure 3, E–J). We undertook a novel analysis that
characterizes the physical relationship between IMCL and
mitochondria. There was no difference in the proportion of
IMCL juxtaposed with mitochondria (i.e., the proportion of IMCL
in contact with mitochondria) in both the SS (lean: 41.268.5% vs.
obese: 39.764.6%) and IMF (lean: 40.9615.2% vs. obese:
37.164.6%) regions between the two groups (Figure 4).
Insulin signaling, glucose uptake and lipid
metabolites. Basal Akt phosphorylation at Ser473 residue, a
key step in insulin-stimulated glucose transport activity, and
GLUT4 protein content were not different between the two
groups (Figure 5A). We also examined intracellular fatty acid
intermediates (DAG and ceramide) and did not observe any
significant differences in these variables between the two groups
(Figure 5B).
Correlations. HOMA-IR showed a positive correlation with
BMI (r=0.37; P#0.03), waist circumference (r=0.44; P#0.01),
and body fat percentage (r=0.53; P#0.01). Morphological
measures of mitochondrial content (i.e., mitochondrial density),
in the SS region (r=20.34; P=0.051) and IMF region (r=20.29;
P=0.096) exhibited an inverse relationship with HOMA-IR
(Table S1). A tendency for a positive relationship with HOMA-
IR was found for SS IMCL size (r=0.28; P=0.119) and SS IMCL
density (r=0.25; P=0.152) (Table S1). Regarding IMCL and
mitochondria juxtaposition, HOMA-IR showed a tendency for an
Table 2. Metabolic characteristics.
Lean Obese
Pre-
training
Post-
training Pre-training
Post-
training
Total cholesterol (mM) 4.860.4 4.660.3 5.360.4 5.360.4
Triglyceride (mM) 0.960.1 0.860.1 1.560.2A 1.560.2B
HDL cholesterol (mM) 1.560.1 1.460.1 1.260.1A 1.260.1
LDL cholesterol (mM) 2.860.3 2.860.3 3.460.3 3.460.3
FFA (mM) 0.360.1 0.560.1C 0.560.1A 0.660.1C
FPG (mM) 5.460.1 5.560.1 5.760.2 5.760.2
FPI (mU.mL21) 8.160.9 7.660.9 12.161.4A 10.261.1
2-h PG (mM) 4.960.2 4.460.3C 7.160.7A 5.460.6C
2-h PI (mU.mL21) 25.166.6 26.564.9 74.3616.9A 39.165.2
Data are presented as means 6 SEM.
AObese group data significantly different from lean group data, P#0.04.
BObese group data significantly different from lean group data, P#0.01.
CPost-training significantly different from pre-training (main effect), P#0.03.
2-h PG, 2-h plasma glucose; 2-h PI, 2-h plasma insulin; FFA, free fatty acid; FPG,
fasting plasma glucose; FPI, fasting plasma insulin.
doi:10.1371/journal.pone.0066322.t002
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inverse relationship in both the SS region (r=20.29; P=0.101)
and IMF region (r=20.30; P=0.086) (Table S2). HOMA-IR also
showed a tendency for an inverse relationship with COXII
(r=20.32; P=0.095) and COXIV (r=20.35; P=0.052) protein
content (Table S3).
Effect of Endurance Exercise Training
Subject characteristics. Twelve weeks of endurance exer-
cise training increased aerobic capacity by 18% in lean men and
by 15% in obese men (P#0.001; Table 1). Waist circumference
was reduced by 4% in lean men and by 3% in obese men
(P#0.001); whereas, body weight, BMI, fat mass, FFM, and body
fat percentage were unchanged by training and remained
markedly higher in the obese men (P#0.02; Table 1). Endurance
training increased FFA concentration (P#0.03); whereas total
cholesterol, triglyceride, HDL-cholesterol and LDL-cholesterol
concentrations remained unchanged between groups (Table 2).
Oral glucose tolerance test and insulin
resistance. Endurance training induced a significant reduction
(19%) in the 2-h plasma glucose concentration (from 6.060.5 to
4.960.3, P#0.01), and a 35% reduction in the 2-h plasma insulin
concentration (from 49.7610.6 to 32.463.8, P=0.07). Endurance
training had no effect on the plasma glucose concentration during
the OGTT (AUCglucose) (Figure 1A). Endurance training had no
effect on the plasma insulin concentration during the OGTT
(AUCinsulin), which remained significantly higher post-training in
the obese group (Figure 1B). Endurance training tended to
decrease HOMA-IR by 17% (2.1760.19 vs. 2.6060.30, post- vs.
pre-training, respectively, P=0.10; Figure 1C).
Biomarkers of mitochondrial content. Endurance training
did not alter whole muscle PGC-1a protein content (Figure 2A)
but did increase the protein content of CS (P#0.04), COXII
(P#0.0001), and COXIV (P#0.001) (Figure 2A) as well as the
maximal activities of CS (P#0.001), COX (P#0.03), and SCHAD
(P#0.01) (Figure 2B). The effect of endurance training on muscle
content of mtDNA was assessed for 8 of the 18 participants, those
for whom sufficient pre- and post-training sample were available.
Endurance training trended towards an increase in mtDNA copy
number by 89% (11366389 vs. 278261125, pre- vs. post-training,
P=0.10; Figure 2C).
Intramyocellular lipid and mitochondrial content. A
summary of IMCL and mitochondrial morphology and sub-
cellular distribution following endurance training is provided in
Table 3. Lean and obese men had similar IMCL content in both
the SS and IMF regions following endurance training (Figure 3).
Endurance training decreased IMCL size in the SS region (228%,
P#0.01), but tended to increase IMCL size in the IMF region
(+40%, P=0.09) (Figure 3E). Endurance training decreased the
number of lipid droplets in the SS region (222%, P#0.001), but
increased the number of lipid droplets in the IMF region (+49%,
P#0.05) (Figure 3F). Endurance training decreased IMCL density
in the SS region (243%, P#0.001; Figure 3G), while it increased
IMF IMCL density (+139%, P#0.02; Figure 3G).
Lean and obese men had similar mitochondrial content in both
the SS and IMF regions following endurance training (Figure 3).
Endurance training increased mitochondria size in the SS region
(P#0.0001) and IMF region (P#0.001) by a similar magnitude
(40%) in both groups (Figure 3H). The total number of
mitochondria in either the SS or IMF sub-cellular regions were
unaffected by training (Figure 3I). Endurance training increased
mitochondrial density in the IMF region (+83%, P#0.01) to a
greater degree than the SS region (+52%, P#0.01) (IMF vs. SS,
P#0.03; Figure 3J). Endurance training increased the proportion
of IMCL droplets juxtaposed with mitochondria by 19% in the SS
Figure 1. Results of the oral glucose tolerance test. Mean plasma
concentrations of glucose (A) and insulin (B) during a 75-g oral glucose
tolerance test, and (C) the homeostasis model assessment index of
insulin resistance (HOMA-IR) in lean (n= 9) and obese (n= 9) men prior
to and following 12-wk endurance training. (A) P= 0.04 and P=0.28 for
the comparison of the areas under the curve for glucose (AUCglucose) of
lean and obese men, pre- and post-training, respectively. 2-hr plasma
glucose concentration: *P#0.01 lean vs. obese pre-training; { P#0.01
pre- vs. post-training (main effect). (B) P=0.02 and P=0.02 for the
comparison of the areas under the curve for insulin (AUCinsulin) of lean
and obese men, pre- and post-training, respectively. Fasting plasma
insulin concentration: *P#0.03 lean vs. obese pre-training; 2-hr plasma
insulin concentration: {P#0.02 lean vs. obese pre-training; `P= 0.07 pre-
vs. post-training (main effect). (C) HOMA-IR was 68% higher in the
obese vs. lean men pre-training and decreased by 17% post-training.
*P#0.02 lean vs. obese pre-training; P= 0.10 pre- vs. post-training (main
effect).
doi:10.1371/journal.pone.0066322.g001
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Figure 2. Markers of mitochondrial function. (A) Mitochondrial protein content assessed by Western blot and (B) mitochondrial maximal
enzyme activity in skeletal muscle of lean (n=9) and obese (n= 9) men prior to and following 12-wk endurance training. (A) PGC-1a, peroxisome
proliferator-activated receptor-c coactivator-1a; CS, citrate synthase; COX, cytochrome c oxidase - subunits II and IV. Results were normalized to b-
actin protein content. *P#0.04 pre- vs. post-training (main effect). (B) CS, citrate synthase; COX, cytochrome c oxidase; SCHAD, short-chain b-
hydroxyacyl-CoA dehydrogenase. *P#0.03 pre- vs. post-training (main effect). (C) Mitochondrial DNA (mtDNA) copy number determined by real-time
quantitative PCR using a TaqMan probe against NADH dehydrogenase 4 (ND4) and b-globin. mtDNA copy number was calculated as the ratio of ND4
to b-globin in skeletal muscle of lean (n= 3) and obese (n= 5) men prior to and following 12-wk endurance training. *P=0.10 pre- vs. post-training
(main effect).
doi:10.1371/journal.pone.0066322.g002
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region (P=0.08), and by 55% in the IMF region (P#0.02;
Figure 4).
Insulin signaling, glucose uptake and lipid
metabolites. Endurance training increased the phosphoryla-
tion of AktSer473 protein by 63% (from 0.6560.08 to 0.9060.12,
P#0.03) and resting whole muscle GLUT4 protein by 227% (from
1.5260.21 to 3.2660.67, P#0.01; Figure 5A) but had no effect on
either DAG or ceramide content (Figure 5B).
Correlations. Change in HOMA-IR (post-training vs. pre-
training values) showed a positive correlation with a change in SS
lipid droplet size (r=0.55; P=0.027) and a change in SS lipid
droplet density (r=0.50; P=0.049) (Table S4). Additional
correlation analyses are reported in Table S5 and Table S6.
Discussion
In this study we have shown that several biomarkers of
mitochondrial content were not differentially altered in skeletal
muscle of obese men compared with healthy lean controls, despite
the obese being insulin resistant. We also found that obese men did
not have higher skeletal muscle IMCL, DAG or ceramide content
than lean controls. It is important to note that our subjects were
strictly matched for physical activity status, which we propose are
vital measures that can confound the assessment of mitochondrial
pathology associated with insulin resistance. The robust effect of
moderate-intensity endurance exercise training stimulating mito-
chondrial capacity was clearly demonstrated but was not related to
obesity or insulin sensitivity. The nature of the study design
ensured that the potential confounding factors such as weight loss
and/or dietary manipulation did not confound the interpretation
of the true effects of endurance exercise training upon the variables
measured in the current study. Our novel observation is that
exercise training mediated a differential response on the localiza-
tion, and magnitude of effect, upon both IMCL and mitochondrial
cellular fractions. Finally, we found weak positive relationships
between HOMA-IR values and SS lipid droplets, but a strong/
moderate inverse relationship with mitochondrial density and
IMCL/mitochondrial juxtaposition in both SS and IMF regions.
Figure 3. Transmission electron microscopy assessment of intramyocellular lipid and mitochondrial content. Micrographs of a skeletal
muscle cell illustrating subsarcolemmal (A) and intermyofibrillar (B) intramyocellular lipid (IMCL) and mitochondria prior to (A,B) and following 12-wk
endurance training (C,D). Subsarcolemmal (SS) IMCL and mitochondria are located between the sarcolemma and the most superficial myofibrils. The
intermyofibrillar (IMF) IMCL and mitochondria are located between parallel bundles of myofibrils. The micrographs (X6,500 magnification, scale bar:
1 mm) were obtained from a biopsy of the vastus lateralis muscle from an obese participant. L, intramyocellular lipid droplet; M, mitochondria, Z, Z-
line. IMCL size (E), number (F), and density (G) in SS and IMF regions of skeletal muscle of lean (n= 9) and obese (n= 9) men prior to and following 12-
wk endurance training. *P#0.05 pre- vs. post-training (main effect). Mitochondria size (H), number (I), and density (J) in SS and IMF regions of skeletal
muscle of lean (n=9) and obese (n= 9) men prior to and following 12-wk endurance training. *P#0.01 pre- vs. post-training (main effect).
doi:10.1371/journal.pone.0066322.g003
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Our novel findings are supported by a growing body of evidence
that indicates that insulin resistance is not strongly associated with
mitochondrial capacity in muscle [37,38,39,40,41]. Discordance
with studies supporting the etiological basis of mitochondrial
dysfunction in insulin resistance may be explained by differences in
study design (e.g., heterogeneity in physical fitness, co-morbidities
associated with adiposity, age) and/or methodological differences
in assessing mitochondrial function. In contrast to other studies
[10,11], where a large difference in demographics existed between
the groups, participants in our study were appropriately age- and
physical activity-matched sedentary, non-diabetic, lean and obese
men. Considering that individuals with obesity, insulin resistance
and T2D are generally physically inactive, the impairments in
oxidative metabolism might simply be attributed to their sedentary
lifestyle and thus the previous associations between muscle
mitochondrial function and insulin resistance may be confounded
[41,42,43]. This conclusion is supported by a more recent
genome-wide RNA expression analyses that found that the skeletal
muscle transcriptome in T2D was indistinguishable from that of
normal glucose tolerant subjects when subjects were well-matched
for fitness [44]. Additionally, insulin resistant obese men in the
current study experienced robust increases in mitochondrial
content and oxidative function to the same extent as lean controls
in response to endurance training. Such increases in mitochondrial
Figure 4. Transmission electron microscopy assessment of intramyocellular lipid and mitochondrial proximity. Representative
electron micrographs of a skeletal muscle cell illustrating subsarcolemmal (A) and intermyofibrillar (B) intramyocellular lipid (IMCL) juxtaposed with
mitochondria prior to (A,B) and following 12-wk endurance training (C,D). The micrographs (X6,500 magnification, scale bar: 1 mm) were obtained
from a biopsy of the vastus lateralis muscle from an obese participant. Graph represents the proportion of IMCL juxtaposed with mitochondrial (i.e.,
the proportion of IMCL in contact with mitochondria) in subsarcolemmal and intermyofibrillar regions of skeletal muscle of lean (n= 9) and obese
(n=9) men prior to and following 12-wk endurance training. *P#0.02 pre- vs. post-training (main effect).
doi:10.1371/journal.pone.0066322.g004
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content/function were observed in the absence of changes in body
composition. Together these observations indicate that physical
activity is the chief factor modulating overall skeletal muscle
mitochondrial capacity, whereas reduced skeletal muscle mito-
chondrial content/function only partially mediates insulin resis-
tance.
The hallmark of the theory linking insulin resistance to
mitochondrial dysfunction is the accumulation of IMCL whose
altered metabolism impairs insulin signaling [13,22,25]. This
notion is challenged by the ‘‘athlete’s paradox’’ where an increase
in IMCL content in endurance-trained athletes is coupled with
increased mitochondrial content and heightened insulin sensitivity
[15,26,29]. To gain an insight into the proposed IMCL
accumulation phenomenon, we carried out an in-depth analysis
of skeletal muscle IMCL accumulation in this study. We utilized
TEM to specifically assess IMCL content in both SS and IMF
regions and found no difference in skeletal muscle IMCL content
between lean and obese men. This result was inconsistent with the
work by Nielsen and colleagues in which a higher level of SS lipids
but not IMF lipids was reported in obese type 2 diabetic patients
compared with obese non-diabetics and endurance-trained sub-
jects [27]. However, Nielson et al. did not report an analysis
between obese non-diabetics and fitness-matched lean subjects,
which precludes comparisons with the present study, in which all
subjects were non-diabetic and matched for physical activity status
and fitness. Similarly, we did not observe a difference in
mitochondrial subpopulations in insulin-resistant obese vs. lean
men, contrasting with a former report of a depletion of SS
mitochondria [3]. A shortcoming of the study by Ritov et al. [3]
was that aerobic capacity was not quantified in the study
participants, nor was age controlled for. Furthermore, mitochon-
dria were not directly quantified, instead the thickness of the layer
of SS mitochondria was used as a marker of mitochondrial mass
[3]. The SS space thickness may not be the best assessment of
mitochondrial content, since the SS space can be influenced by
lipid droplets and nuclei occupying it. Here, we used more
rigorous methodology to measure mitochondrial content. Further-
more, in comparison with Ritov et al., our obese men were
matched with lean controls thereby diminishing the confounding
effects of differences in physical activity habits between groups.
Each or all of these factors could have contributed to the difference
in findings between studies.
The effect of endurance exercise training on IMCL content in
skeletal muscle is equivocal. While endurance exercise has
previously been shown to lower IMCL content in T2D
[45,46,47], we and others have shown that in non-diabetic
untrained subjects, endurance training elevates IMCL content
[29,48,49], presumably as an adaptation to maximize surface area
and total muscle IMCL content for lipolysis during exercise. We
report here the novel findings that IMCL content is differentially
regulated at the sub-cellular level in myofibers in response to
endurance training. In both lean and obese men, endurance
Table 3. Intramyocellular lipid and mitochondrial morphology.
Lean Obese
Adiposity
Effect
Training
Effect
Pre-training Post-training Pre-training Post-training
Intramyocellular lipid
IMCL size (mm2)
Subsarcolemmal 0.2160.02 0.1460.02 0.2560.04 0.1760.01 P= 0.33 P#0.01
Intermyofibrillar 0.1560.02 0.1960.04 0.1560.02 0.2360.03 P= 0.92 P= 0.09
No. of IMCL (#.mm22)
Subsarcolemmal 0.3960.02 0.3160.04 0.4260.03 0.3260.04 P= 0.36 P#0.001
Intermyofibrillar 0.0560.01 0.0760.01 0.0560.01 0.0760.01 P= 0.83 P#0.05
IMCL density (%)
Subsarcolemmal 7.861.1 4.360.8 10.361.5 5.260.7 P= 0.20 P#0.001
Intermyofibrillar 0.760.1 1.360.3 0.860.2 1.660.3 P= 0.44 P#0.02
Mitochondria
Mitochondria size (mm2)
Subsarcolemmal 0.1160.01 0.1460.01 0.0960.01 0.1360.01 P= 0.19 P#0.0001
Intermyofibrillar 0.0960.01 0.1360.01 0.0960.01 0.1360.01 P= 0.32 P#0.001
No. of mitochondria (#.mm22)
Subsarcolemmal 1.4360.16 1.5360.14 1.3160.19 1.3160.12 P= 0.63 P= 0.80
Intermyofibrillar 0.4060.04 0.4560.04 0.3760.05 0.4560.06 P= 0.72 P= 0.20
Mitochondrial density (%)
Subsarcolemmal 14.561.5 20.161.5 11.961.6 15.961.4 P= 0.27 P#0.01
Intermyofibrillar 3.860.5 5.860.5 3.260.4 5.360.5 P= 0.35 P#0.01
IMCL juxtaposed mitochondria (%)
Subsarcolemmal 41.262.8 48.063.3 39.764.6 43.463.2 P= 0.79 P= 0.08
Intermyofibrillar 40.965.1 53.865.0 37.164.6 52.166.4 P= 0.59 P#0.02
Data are presented as means 6 SEM. IMCL, intramyocellular lipid.
doi:10.1371/journal.pone.0066322.t003
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training mediated a significant decrease in IMCL size, number
and density in the SS region, whereas the opposite effect was
observed in IMCL size, number and density in the IMF region.
We additionally demonstrated that the proportion of IMCL
droplets juxtaposed with mitochondria increased in both lean and
obese groups post-training in both sub-cellular regions, potentially
contributing to more efficient substrate oxidation as noted by a
concomitant increase in b-oxidation following endurance training
in both groups. This novel finding extends some of our previous
analyses conducted in non-obese populations [29,50]. Perhaps
greater efficiency of substrate oxidation through tighter coupling of
IMCL droplets and mitochondria is more indicative of whole-
body insulin sensitivity; as such, we found moderate inverse
associations between HOMA-IR and IMCL/mitochondria juxta-
position in both the SS and IMF regions.
Another new finding from this study is that skeletal muscle
mitochondria respond to training even in obese men with insulin
resistance. We have shown that mitochondrial size and density,
but not number, increase in both the SS and IMF regions; and this
effect is independent of lean and obese groups. This finding
confirms our previous report of increases in total mitochondrial
volume density due to an increase in the size of the mitochondrial
reticulum and not the number of fragments in response to
endurance exercise [29]. In comparison with IMF mitochondria,
SS mitochondria respond to a greater degree, or earlier in time, to
training [27,48]. In the current study, the training-mediated
increase in mitochondrial density in the IMF (+83%) was greater
than the increase in SS mitochondrial density (+52%); opposite to
the pattern previously observed [27,48]. The differences in study
population, duration of endurance exercise training, type I and II
muscle fiber distribution, and the sub-cellular image sampling
methods may partially explain the observed difference.
More active lipid metabolites (DAG and ceramide) have been
implicated in impaired insulin signaling [20,51,52,53]. Itani et al.
found that insulin sensitivity decreased after increasing plasma
NEFA with a lipid infusion during a euglycemic–hyperinsulinemic
clamp, and this occurred in parallel with an increase in
intramuscular DAG, but not ceramide [20]. Straczkowski et al.
[53] showed that lipid infusion reduced insulin sensitivity, and this
coincided with increased muscle ceramide content. Lastly, Bruce
et al. found that glucose tolerance was increased and muscle
ceramide levels were decreased after 8 weeks of training [54]. In
Figure 5. Insulin signaling and lipid metabolite data. (A) Akt phosphorylation at Ser473 residue and GLUT4 protein content assessed by
Western blot and (B) diacylglycerol and ceramide lipid content in skeletal muscle of lean (n= 9) and obese (n=9) men prior to and following 12-wk
endurance training. (A) p-Akt, Akt phosphorylation at Ser473; GLUT4, glucose transporter 4. Results were normalized to b-actin protein content. *
P#0.03 pre- vs. post-training (main effect).
doi:10.1371/journal.pone.0066322.g005
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the present study, we did not find an effect of endurance exercise
training on DAG or ceramide content (despite an increase in
FFAs), nor differences between these lipid intermediates in lean
and obese men at baseline, supporting recent human [55] and
rodent [56] data. Additionally, Serlie et al. found lean and
overweight individuals to have similar muscle ceramide concen-
trations [57]. It is not easy to reconcile these findings, but it can be
speculated that a threshold of obesity may exist, above which
muscle ceramide accumulates and influences insulin signaling and
thus insulin sensitivity. Furthermore, we cannot exclude the
possibility that muscle long chain fatty acyl-CoA may have
influenced insulin sensitivity. Given that robust changes in
mitochondrial and b-oxidation capacity occurred without alter-
ations in DAG or ceramide muscle content in the present study
further adds to the complexity in understanding the link between
IMCL-mitochondria and glucose homeostasis.
We did not find any differences in phosphorylation of AktSer473,
a key downstream step for the activation of glucose transport, and
GLUT4 protein contents between lean and obese men. Although
previous investigations have reported reduced Akt activity [52,58],
it is important to note that these studies were conducted in
cultured muscle cells from severely obese women under insulin
stimulated conditions [58] or obese men and women during
euglycemic-hyperinsulinemic clamp settings [52], and it is not
clear whether physical activity and/or physical fitness were strictly
controlled for; consequently, their findings may not be represen-
tative of obese individuals with less severe pathology. In a previous
study, Hood et al. reported reduced skeletal muscle Akt phos-
phorylation in the basal state in response to endurance training
(high-intensity interval training) in healthy men and women [59].
Liu et al. have recently hypothesized that basal Akt activation in
skeletal muscle is linked to reduced mitochondrial content and
insulin resistance [60]. Akt has been shown to directly phosphor-
ylate PGC-1a, leading to its inhibition and degradation [61]. In
response to a high-fat diet, mice become insulin resistant
concomitant with an increase in basal Akt activation, a reduction
in PGC-1a protein, and a decrease in mitochondrial content in
skeletal muscle [60]. In response to 12 weeks of endurance exercise
training, we observed a trend in decreasing insulin resistance
(HOMA-IR), an increase in basal Akt activation, and an increase
in mitochondrial content in skeletal muscle. Although these
findings conflict with the aforementioned studies suggesting a link
between elevated basal Akt activation and insulin resistance, our
study underscores the complexity of the issue linking insulin
signaling pathways in obesity and exercise. The absence of insulin
signaling impairments coincide with the lack of higher IMCL
content and no differences in DAG or ceramide in the skeletal
muscle of insulin resistant obese men, which in turn are consistent
with our measurements showing uncompromised mitochondrial
function/b-oxidation and mitochondrial morphology. Together,
these results suggest that when confounding factors such as age
and physical activity status are controlled for; insulin resistance is
only partially explained by skeletal muscle mitochondrial content
and IMCL content or distribution, but not DAG or ceramides.
This conclusion is further supported by our previous work in older
adults where we have shown that mitochondrial function was not
just influenced by age per se, but was strongly modulated by the
physical activity status of the participants [28,29].
We did not observe a clear effect of endurance training on
whole-body insulin resistance. It is important to note that this
observation was made in the absence of body composition changes
(i.e., weight loss); and a ,20% increase in aerobic capacity. Our
observation is in accordance with our previous study in which
three months of moderate-intensity cycling did not improve insulin
resistance in lean and obese women [30]. Of note, women in the
latter study did not lose body weight or alter body composition
after exercise training. These results are consistent with those
reporting only modest or no improvements in insulin sensitivity
with exercise training in middle-aged or older men and women
[62] or when the effects of weight loss [63] and the last exercise
session [64] are accounted for.
It must be acknowledged that the present findings are based on
a small sample of inactive adult men. As such, certain results may
be attributed to false-negatives due to the lack of statistical power.
For example, the present study had only 56% power to detect a
statistically significant difference in HOMA-IR in response to
endurance exercise training. In order to have potentially observed
a statistical reduction in HOMA-IR, given the variability in our
study population, approximately 88 adult men would have had to
be enrolled. Despite this, however, we were able to detect
significant changes in many muscle metabolic parameters after 12
weeks of endurance training. As this study was conducted in men
only, and given that sex differences exist in the relationship
between IMCL and obesity or insulin resistance, our study limits
any direct comparisons to studies reporting data in both men and
women. On the basis of our encouraging findings for the efficacy
of moderate-intensity endurance exercise training for improving
markers of metabolic health, future studies should include larger
sample sizes, including both men and women, and a type 2
diabetic group to directly assess the potential health-promoting
adaptations to this type of training. Future studies should also use
more direct measures of muscle insulin sensitivity, glycemic
control, and mitochondrial function because the assessment of
insulin resistance using HOMA-IR and the assessment of
mitochondrial function using mitochondrial proteins and enzyme
activities of mitochondrial complexes in the present study is limited
by the fact that it was based with a single fasting blood sample and
frozen muscle samples, respectively. Muscle glucose uptake is
primarily regulated by insulin signaling to GLUT4 translocation
from intracellular pools to the sarcolemma. We assessed total
GLUT4 protein content in resting muscle biopsy samples in this
study and as such cannot determine whether endurance exercise
training had an influence on GLUT4 trafficking. However, an
increase in total GLUT4 is a relatively rapid response and seems to
be important in mediating some of the increase in muscle glucose
uptake and insulin sensitivity after exercise [65,66,67]. Finally,
quantification of IMCL and mitochondria in humans is further
complicated by a heterogeneous myocyte or fiber composition.
Type I fibers have been reported to be less abundant in obese
and/or type 2 diabetic patients [68], but it is unclear if these
differences persist when controlled for physical activity/fitness.
Although we have substantiated our TEM data with additional
biochemical markers of mitochondrial function and insulin
resistance, fiber type composition was not controlled for, hence,
additional studies are needed to link IMCL, fiber type, oxidative
capacity, and activation of specific insulin-signaling proteins.
In conclusion, our results do not primarily support the notion of
impaired skeletal muscle mitochondrial function or IMCL/DAG/
ceramide accumulation per se being linked to insulin resistance in
obese men. Previous associations may in part be due to other
confounders, such as age, co-morbidities and physical activity.
Additionally, this study illustrates that moderate-intensity endur-
ance exercise training, in the absence of weight loss, evokes
favorable mitochondrial adaptations in both lean and insulin-
resistant obese men to a similar extent and differentially regulates
intracellular subpopulations of both IMCL and mitochondria.
Future studies are warranted to further ascertain the molecular
deficits that lead to insulin resistance in the absence of the
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confounding variables of age, physical activity level and diet. We
believe that in light of our current findings and previous
contradictory reports where confounding variables were not
strictly controlled for, it is imperative to test if insulin resistance
plays a causal role in promoting mitochondrial dysfunction
systemically in obese subjects and patients with type 2 diabetes.
Additionally, it will be of great interest to decipher if insulin
resistance-mediated hormonal dysfunction in obesity modulates
the effects of physical activity and promotes secondary pathology,
such as skeletal muscle mitochondrial dysfunction.
Supporting Information
Table S1 Pearson Correlation Analyses, HOMA-IR vs.
Mitochondria and IMCL Morphology Features.
(DOCX)
Table S2 Pearson Correlation Analyses, HOMA-IR vs.
IMCL and Mitochondria Juxtaposition.
(DOCX)
Table S3 Pearson Correlation Analyses, HOMA-IR vs.
Mitochondria Biochemical Features and Lipid Interme-
diates.
(DOCX)
Table S4 Pearson Correlation Analyses, Change in
HOMA-IR vs. Change in Mitochondria and IMCL
Morphology Features.
(DOCX)
Table S5 Pearson Correlation Analyses, Change in
HOMA-IR vs. Change in IMCL and Mitochondria
Juxtaposition.
(DOCX)
Table S6 Pearson Correlation Analyses, Change in
HOMA-IR vs. Change in Mitochondria Biochemical
Features and Lipid Intermediates.
(DOCX)
Acknowledgments
The authors greatly appreciate all the volunteers who participated in the
study.
Author Contributions
Conceived and designed the experiments: IAS MJH SR MAT. Performed
the experiments: IAS AS AWG NJM JPL GRS. Analyzed the data: IAS
AS. Contributed reagents/materials/analysis tools: GRS SR MAT. Wrote
the paper: IAS. Conducted and coordinated the study: IAS MJH JS.
References
1. Lau DC, Douketis JD, Morrison KM, Hramiak IM, Sharma AM, et al. (2007)
2006 Canadian clinical practice guidelines on the management and prevention
of obesity in adults and children [summary]. CMAJ 176: S1–13.
2. Kelley DE, He J, Menshikova EV, Ritov VB (2002) Dysfunction of
mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51: 2944–
2950.
3. Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster BH, et al. (2005)
Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes.
Diabetes 54: 8–14.
4. Ritov VB, Menshikova EV, Azuma K, Wood R, Toledo FG, et al. (2010)
Deficiency of electron transport chain in human skeletal muscle mitochondria in
type 2 diabetes mellitus and obesity. Am J Physiol Endocrinol Metab 298: E49–
58.
5. Simoneau JA, Colberg SR, Thaete FL, Kelley DE (1995) Skeletal muscle
glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity
and muscle composition in obese women. FASEB J 9: 273–278.
6. Simoneau JA, Kelley DE (1997) Altered glycolytic and oxidative capacities of
skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 83:
166–171.
7. Simoneau JA, Veerkamp JH, Turcotte LP, Kelley DE (1999) Markers of
capacity to utilize fatty acids in human skeletal muscle: relation to insulin
resistance and obesity and effects of weight loss. FASEB J 13: 2051–2060.
8. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI (2004) Impaired
mitochondrial activity in the insulin-resistant offspring of patients with type 2
diabetes. N Engl J Med 350: 664–671.
9. Morino K, Petersen KF, Dufour S, Befroy D, Frattini J, et al. (2005) Reduced
mitochondrial density and increased IRS-1 serine phosphorylation in muscle of
insulin-resistant offspring of type 2 diabetic parents. J Clin Invest 115: 3587–
3593.
10. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, et al. (2003) Coordinated
reduction of genes of oxidative metabolism in humans with insulin resistance and
diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 100:
8466–8471.
11. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, et al. (2003)
PGC-1alpha-responsive genes involved in oxidative phosphorylation are
coordinately downregulated in human diabetes. Nat Genet 34: 267–273.
12. Goodpaster BH, Theriault R, Watkins SC, Kelley DE (2000) Intramuscular lipid
content is increased in obesity and decreased by weight loss. Metabolism 49:
467–472.
13. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, et al. (1997) Skeletal
muscle triglyceride levels are inversely related to insulin action. Diabetes 46:
983–988.
14. Perseghin G, Scifo P, De Cobelli F, Pagliato E, Battezzati A, et al. (1999)
Intramyocellular triglyceride content is a determinant of in vivo insulin
resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy
assessment in offspring of type 2 diabetic parents. Diabetes 48: 1600–1606.
15. van Loon LJ, Koopman R, Manders R, van der Weegen W, van Kranenburg
GP, et al. (2004) Intramyocellular lipid content in type 2 diabetes patients
compared with overweight sedentary men and highly trained endurance
athletes. Am J Physiol Endocrinol Metab 287: E558–565.
16. Kelley DE, Goodpaster BH, Storlien L (2002) Muscle triglyceride and insulin
resistance. Annu Rev Nutr 22: 325–346.
17. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, et al. (1999) Effects
of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol
3-kinase activity. J Clin Invest 103: 253–259.
18. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, et al. (1999) Free fatty
acid-induced insulin resistance is associated with activation of protein kinase C
theta and alterations in the insulin signaling cascade. Diabetes 48: 1270–1274.
19. Yu C, Chen Y, Cline GW, Zhang D, Zong H, et al. (2002) Mechanism by which
fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-
associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277:
50230–50236.
20. Itani SI, Ruderman NB, Schmieder F, Boden G (2002) Lipid-induced insulin
resistance in human muscle is associated with changes in diacylglycerol, protein
kinase C, and IkappaB-alpha. Diabetes 51: 2005–2011.
21. Morino K, Petersen KF, Shulman GI (2006) Molecular mechanisms of insulin
resistance in humans and their potential links with mitochondrial dysfunction.
Diabetes 55 Suppl 2: S9–S15.
22. Lowell BB, Shulman GI (2005) Mitochondrial dysfunction and type 2 diabetes.
Science 307: 384–387.
23. Federico A, Manneschi L, Paolini A (1987) Biochemical difference bewteen
intermyofibrilliar and subsarcolemmal mitochondria from human muscle.
J Inher Metab Dis 10: 242–246.
24. Chomentowski P, Coen PM, Radikova Z, Goodpaster BH, Toledo FG (2011)
Skeletal muscle mitochondria in insulin resistance: differences in intermyofi-
brillar versus subsarcolemmal subpopulations and relationship to metabolic
flexibility. J Clin Endocrinol Metab 96: 494–503.
25. Krssak M, Falk Petersen K, Dresner A, DiPietro L, Vogel SM, et al. (1999)
Intramyocellular lipid concentrations are correlated with insulin sensitivity in
humans: a 1H NMR spectroscopy study. Diabetologia 42: 113–116.
26. Goodpaster BH, He J, Watkins S, Kelley DE (2001) Skeletal muscle lipid content
and insulin resistance: evidence for a paradox in endurance-trained athletes.
J Clin Endocrinol Metab 86: 5755–5761.
27. Nielsen J, Mogensen M, Vind BF, Sahlin K, Hojlund K, et al. (2010) Increased
subsarcolemmal lipids in type 2 diabetes: effect of training on localization of
lipids, mitochondria, and glycogen in sedentary human skeletal muscle.
Am J Physiol Endocrinol Metab 298: E706–713.
28. Safdar A, Hamadeh MJ, Kaczor JJ, Raha S, Debeer J, et al. (2010) Aberrant
mitochondrial homeostasis in the skeletal muscle of sedentary older adults. PLoS
One 5: e10778.
29. Tarnopolsky MA, Rennie CD, Robertshaw HA, Fedak-Tarnopolsky SN,
Devries MC, et al. (2007) Influence of endurance exercise training and sex on
intramyocellular lipid and mitochondrial ultrastructure, substrate use, and
mitochondrial enzyme activity. Am J Physiol Regul Integr Comp Physiol 292:
R1271–1278.
30. Devries MC, Hamadeh MJ, Glover AW, Raha S, Samjoo IA, et al. (2008)
Endurance training without weight loss lowers systemic, but not muscle,
oxidative stress with no effect on inflammation in lean and obese women. Free
Radic Biol Med 45: 503–511.
Mitochondrial Function and Insulin Resistance
PLOS ONE | www.plosone.org 12 June 2013 | Volume 8 | Issue 6 | e66322
31. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985)
Homeostasis model assessment: insulin resistance and beta-cell function from
fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412–
419.
32. Emoto M, Nishizawa Y, Maekawa K, Hiura Y, Kanda H, et al. (1999)
Homeostasis model assessment as a clinical index of insulin resistance in type 2
diabetic patients treated with sulfonylureas. Diabetes Care 22: 818–822.
33. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement
with the Folin phenol reagent. J Biol Chem 193: 265–275.
34. Watt MJ, Dzamko N, Thomas WG, Rose-John S, Ernst M, et al. (2006) CNTF
reverses obesity-induced insulin resistance by activating skeletal muscle AMPK.
Nat Med 12: 541–548.
35. Handschin C, Spiegelman BM (2008) The role of exercise and PGC1alpha in
inflammation and chronic disease. Nature 454: 463–469.
36. Safdar A, Little JP, Stokl AJ, Hettinga BP, Akhtar M, et al. (2011) Exercise
increases mitochondrial PGC-1{alpha} content and promotes nuclear-mito-
chondrial cross-talk to coordinate mitochondrial biogenesis. J Biol Chem.
37. Brons C, Jensen CB, Storgaard H, Alibegovic A, Jacobsen S, et al. (2008)
Mitochondrial function in skeletal muscle is normal and unrelated to insulin
action in young men born with low birth weight. J Clin Endocrinol Metab 93:
3885–3892.
38. Nair KS, Bigelow ML, Asmann YW, Chow LS, Coenen-Schimke JM, et al.
(2008) Asian Indians Have Enhanced Skeletal Muscle Mitochondrial Capacity to
Produce ATP in Association With Severe Insulin Resistance. Diabetes. 1166–
1175.
39. De Feyter HM, van den Broek NM, Praet SF, Nicolay K, van Loon LJ, et al.
(2008) Early or advanced stage type 2 diabetes is not accompanied by in vivo
skeletal muscle mitochondrial dysfunction. Eur J Endocrinol 158: 643–653.
40. Bajpeyi S, Pasarica M, Moro C, Conley K, Jubrias S, et al. (2011) Skeletal
Muscle Mitochondrial Capacity and Insulin Resistance in Type 2 Diabetes.
J Clin Endocrin Metab 96.
41. Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsoe R, et al. (2007)
Patients with type 2 diabetes have normal mitochondrial function in skeletal
muscle. Diabetologia 50: 790–796.
42. Timmons JA, Norrbom J, Scheele C, Thonberg H, Wahlestedt C, et al. (2006)
Expression profiling following local muscle inactivity in humans provides new
perspective on diabetes-related genes. Genomics 87: 165–172.
43. Hawley JA, Lessard SJ (2007) Mitochondrial function: use it or lose it.
Diabetologia 50: 699–702.
44. Gallagher IJ, Scheele C, Keller P, Nielsen AR, Remenyi J, et al. (2010)
Integration of microRNA changes in vivo identifies novel molecular features of
muscle insulin resistance in type 2 diabetes. Genome Med 2: 9.
45. Bruce CR, Kriketos AD, Cooney GJ, Hawley JA (2004) Disassociation of muscle
triglyceride content and insulin sensitivity after exercise training in patients with
Type 2 diabetes. Diabetologia 47: 23–30.
46. Kim HJ, Lee JS, Kim CK (2004) Effect of exercise training on muscle glucose
transporter 4 protein and intramuscular lipid content in elderly men with
impaired glucose tolerance. Eur J Appl Physiol 93: 353–358.
47. He J, Goodpaster BH, Kelley DE (2004) Effects of weight loss and physical
activity on muscle lipid content and droplet size. Obes Res 12: 761–769.
48. Howald H, Hoppeler H, Claassen H, Mathieu O, Straub R (1985) Influences of
endurance training on the ultrastructural composition of the different muscle
fiber types in humans. Pflugers Arch 403: 369–376.
49. Phillips SM, Green HJ, Tarnopolsky MA, Heigenhauser GJ, Grant SM (1996)
Progressive effect of endurance training on metabolic adaptations in working
skeletal muscle. Am J Physiol 270: E265–272.
50. Devries MC, Lowther SA, Glover AW, Hamadeh MJ, Tarnopolsky MA (2007)
IMCL area density, but not IMCL utilization, is higher in women during
moderate-intensity endurance exercise, compared with men. Am J Physiol Regul
Integr Comp Physiol 293: R2336–2342.
51. Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106:
171–176.
52. Adams JM, 2nd, Pratipanawatr T, Berria R, Wang E, DeFronzo RA, et al.
(2004) Ceramide content is increased in skeletal muscle from obese insulin-
resistant humans. Diabetes 53: 25–31.
53. Straczkowski M, Kowalska I, Baranowski M, Nikolajuk A, Otziomek E, et al.
(2007) Increased skeletal muscle ceramide level in men at risk of developing type
2 diabetes. Diabetologia 50: 2366–2373.
54. Bruce CR, Thrush AB, Mertz VA, Bezaire V, Chabowski A, et al. (2006)
Endurance training in obese humans improves glucose tolerance and
mitochondrial fatty acid oxidation and alters muscle lipid content. Am J Physiol
Endocrinol Metab 291: E99–E107.
55. Skovbro M, Baranowski M, Skov-Jensen C, Flint A, Dela F, et al. (2008) Human
skeletal muscle ceramide content is not a major factor in muscle insulin
sensitivity. Diabetologia 51: 1253–1260.
56. Hoy AJ, Brandon AE, Turner N, Watt MJ, Bruce CR, et al. (2009) Lipid and
insulin infusion-induced skeletal muscle insulin resistance is likely due to
metabolic feedback and not changes in IRS-1, Akt, or AS160 phosphorylation.
Am J Physiol Endocrinol Metab 297: E67–75.
57. Serlie MJ, Meijer AJ, Groener JE, Duran M, Endert E, et al. (2007) Short-term
manipulation of plasma free fatty acids does not change skeletal muscle
concentrations of ceramide and glucosylceramide in lean and overweight
subjects. J Clin Endocrinol Metab 92: 1524–1529.
58. Bell JA, Reed MA, Consitt LA, Martin OJ, Haynie KR, et al. (2010) Lipid
partitioning, incomplete fatty acid oxidation, and insulin signal transduction in
primary human muscle cells: effects of severe obesity, fatty acid incubation, and
fatty acid translocase/CD36 overexpression. J Clin Endocrinol Metab 95: 3400–
3410.
59. Hood MS, Little JP, Tarnopolsky MA, Myslik F, Gibala MJ (2011) Low-volume
interval training improves muscle oxidative capacity in sedentary adults. Med
Sci Sports Exerc 43: 1849–1856.
60. Liu HY, Hong T, Wen GB, Han J, Zuo D, et al. (2009) Increased basal level of
Akt-dependent insulin signaling may be responsible for the development of
insulin resistance. Am J Physiol Endocrinol Metab 297: E898–906.
61. Li X, Monks B, Ge Q, Birnbaum MJ (2007) Akt/PKB regulates hepatic
metabolism by directly inhibiting PGC-1alpha transcription coactivator. Nature
447: 1012–1016.
62. Short KR, Vittone JL, Bigelow ML, Proctor DN, Rizza RA, et al. (2003) Impact
of aerobic exercise training on age-related changes in insulin sensitivity and
muscle oxidative capacity. Diabetes 52: 1888–1896.
63. Ross R, Dagnone D, Jones PJ, Smith H, Paddags A, et al. (2000) Reduction in
obesity and related comorbid conditions after diet-induced weight loss or
exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern
Med 133: 92–103.
64. Segal KR, Edano A, Abalos A, Albu J, Blando L, et al. (1991) Effect of exercise
training on insulin sensitivity and glucose metabolism in lean, obese, and diabetic
men. J Appl Physiol 71: 2402–2411.
65. Ren JM, Semenkovich CF, Gulve EA, Gao J, Holloszy JO (1994) Exercise
induces rapid increases in GLUT4 expression, glucose transport capacity, and
insulin-stimulated glycogen storage in muscle. J Biol Chem 269: 14396–14401.
66. Houmard JA, Hickey MS, Tyndall GL, Gavigan KE, Dohm GL (1995) Seven
days of exercise increase GLUT-4 protein content in human skeletal muscle.
J Appl Physiol 79: 1936–1938.
67. Holloszy JO (2009) Skeletal muscle ‘‘mitochondrial deficiency’’ does not mediate
insulin resistance. Am J Clin Nutr 89: 463S–466S.
68. Tanner CJ, Barakat HA, Dohm GL, Pories WJ, MacDonald KG, et al. (2002)
Muscle fiber type is associated with obesity and weight loss. Am J Physiol
Endocrinol Metab 282: E1191–1196.
Mitochondrial Function and Insulin Resistance
PLOS ONE | www.plosone.org 13 June 2013 | Volume 8 | Issue 6 | e66322
